Xenetic Biosciences, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xenetic Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Xenetic Biosciences, Inc. Return On Equity for the quarter ending June 30, 2024 was -51 %, a 60.9% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Return On Equity for 2023 was -36.4 %, a 16.3% increase from 2022.
  • Xenetic Biosciences, Inc. annual Return On Equity for 2022 was -43.5 %, a 14.5% decline from 2021.
  • Xenetic Biosciences, Inc. annual Return On Equity for 2021 was -38 %, a 54.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -36.4 +7.07 +16.3% Jan 1, 2023 Dec 31, 2023
2022 -43.5 -5.5 -14.5% Jan 1, 2022 Dec 31, 2022
2021 -38 +46.3 +54.9% Jan 1, 2021 Dec 31, 2021
2020 -84.3 +4.74 +5.32% Jan 1, 2020 Dec 31, 2020
2019 -89.1 -26.8 -43% Jan 1, 2019 Dec 31, 2019
2018 -62.3 -33.1 -113% Jan 1, 2018 Dec 31, 2018
2017 -29.2 +616 +95.5% Jan 1, 2017 Dec 31, 2017
2016 -645 -459 -246% Jan 1, 2016 Dec 31, 2016
2015 -186 -93.8 -101% Jan 1, 2015 Dec 31, 2015
2014 -92.6 +188 +67% Jan 1, 2014 Dec 31, 2014
2013 -280 -278 -11391% Jan 1, 2013 Dec 31, 2013
2012 -2.44 Sep 1, 2011 Aug 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.